Ischemic disorders, such as myocardial infarction, stroke, and peripheral vascular disease,
are the most common causes of debilitating disease and death in westernized cultures. The …

Mesenchymal stem cells (MSCs) are promising alternative agents for the treatment of
inflammatory disorders due to their immunomodulatory functions, and several clinical trials …

Cell transplantation is a promising therapy for a myriad of debilitating diseases; however,
current delivery protocols using direct injection result in poor cell viability. We demonstrate …

Current protocols to encapsulate cells within physical hydrogels require substantial changes
in environmental conditions (pH, temperature, or ionic strength) to initiate gelation. These …

Creatine kinase catalyses the reversible transphosphorylation of creatine by ATP. In the cell,
creatine kinase isoenzymes are specifically localized at strategic sites of ATP consumption …

Background: Adipose-derived stem cells and other stromal vascular fraction cells were used
more often for stem cell therapy, even though limitations such as poor cell retention rate …

No treatment currently exists to restore lost neurological function after stroke. A growing
number of studies highlight the potential of stem cell transplantation as a novel therapeutic …

One of the exciting advances in modern medicine and life science is cell-based
neurovascular regeneration of damaged brain tissues and repair of neuronal structures. The …

Select functional outcome tests commonly used for evaluating sensorimotor and cognitive
capacity in rodents with focal intracerebral ischemic or hemorrhagic injury are described …

Cortical stem cell transplantation may help replace lost brain cells after stroke and improve
the functional outcome. In this study, we transplanted human embryonic stem cell (hESC) …